A biotechnology company whose research and intellectual property has helped to create the Oxford-AstraZeneca Covid vaccine has raised new investment from venture capitalists.
Oxford-based Vaccitech has agreed the funds – understood to be as much as £10million – from Future Planet Capital which also invests in health, climate change and education projects.
{iframe}https://www.thisismoney.co.uk/money/markets/article-9089409/Venture-capitalist-injects-10m-Oxford-vaccine-firm-Vaccitech.html{/iframe}